GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Cyclically Adjusted FCF per Share

Sumitomo Pharma Co (Sumitomo Pharma Co) Cyclically Adjusted FCF per Share : $0.11 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was $-0.269. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.11 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Sumitomo Pharma Co's average Cyclically Adjusted FCF Growth Rate was -85.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -52.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was -23.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Sumitomo Pharma Co was 11.10% per year. The lowest was -52.10% per year. And the median was 4.45% per year.

As of today (2024-05-22), Sumitomo Pharma Co's current stock price is $2.26. Sumitomo Pharma Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.11. Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF of today is 20.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sumitomo Pharma Co was 35.42. The lowest was 5.01. And the median was 12.53.


Sumitomo Pharma Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Cyclically Adjusted FCF per Share Chart

Sumitomo Pharma Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.69 1.26 1.01 0.11

Sumitomo Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 0.48 0.33 0.17 0.11

Competitive Comparison of Sumitomo Pharma Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF falls into.



Sumitomo Pharma Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sumitomo Pharma Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.269/107.2000*107.2000
=-0.269

Current CPI (Mar. 2024) = 107.2000.

Sumitomo Pharma Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.000 98.000 0.000
201409 0.000 98.500 0.000
201412 0.000 97.900 0.000
201503 0.000 97.900 0.000
201506 0.000 98.400 0.000
201509 0.000 98.500 0.000
201512 0.000 98.100 0.000
201603 0.000 97.900 0.000
201606 0.000 98.100 0.000
201609 0.000 98.000 0.000
201612 0.000 98.400 0.000
201703 0.000 98.100 0.000
201706 0.394 98.500 0.429
201709 0.356 98.800 0.386
201712 0.270 99.400 0.291
201803 0.853 99.200 0.922
201806 -0.267 99.200 -0.289
201809 0.250 99.900 0.268
201812 0.206 99.700 0.221
201903 0.615 99.700 0.661
201906 0.119 99.800 0.128
201909 0.431 100.100 0.462
201912 0.079 100.500 0.084
202003 0.137 100.300 0.146
202006 -0.030 99.900 -0.032
202009 0.535 99.900 0.574
202012 1.899 99.300 2.050
202103 0.586 99.900 0.629
202106 -0.817 99.500 -0.880
202109 -0.001 100.100 -0.001
202112 0.756 100.100 0.810
202203 0.411 101.100 0.436
202206 0.173 101.800 0.182
202209 0.259 103.100 0.269
202212 0.431 104.100 0.444
202303 -0.902 104.400 -0.926
202306 -2.394 105.200 -2.440
202309 -0.826 106.200 -0.834
202312 -1.026 106.800 -1.030
202403 -0.269 107.200 -0.269

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Sumitomo Pharma Co  (OTCPK:DNPUF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=2.26/0.11
=20.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Sumitomo Pharma Co was 35.42. The lowest was 5.01. And the median was 12.53.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Sumitomo Pharma Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.